Lei 2013 TNF antagonism improves neurological recovery in murine intracerebral hemorrhage
Complete the Request a Consultation Form or call +1 (561) 353-9707 to request a phone or in-office consultation with an INR medical provider.
Form HereEdward Tobinick, M.D., the founder and Director of the Institute of Neurological Recovery, invented the remarkable breakthrough perispinal etanercept treatment for stroke and chronic brain injury, first used in 2010, now, in 2022, with thousands of patients treated from 91 countries.
In October 2018, the Australian Government announced their designation of substantial funding to study perispinal etanercept(PSE) for treatment of stroke. On January 3, 2020 a university, double-blind, randomized, placebo-controlled, clinical trial confirmed the efficacy of perispinal etanercept for treatment of chronic, post-stroke pain. Dr. Tobinick was instrumental in the design of the university study.
The INR accepts patients for treatment from all parts of the world, and has treated patients from every populated continent of the world.
Scientific articles from hundreds of academic scientists around the world have cited INR publications.
The Institute of Neurological Recovery® (INR®). A decade of pioneering discoveries in medicine. The INR utilizes the pioneering, patented perispinal etanercept (PSE) off-label treatment methods invented by its founder and Medical Director, Edward Tobinick, M.D. The contents of this website, including text, images, and videos are ©2022 INR PLLC, all rights reserved. Reproduction in whole or part prohibited. Issued and pending U.S. and foreign patents, including, but not limited to, U.S. 6419944, 6537549, 6982089, 7214658, 7629311, 8119127, 8236306, 8349323 and 8,900,583; Australian patents 758523 and 2011323616 B2, Canadian patent 2,811,948, European patent ES2620749 (T3), etc., all assigned to TACT IP LLC.
Privacy Policy | Login
Institute of Neurological Recovery – Stroke
1877 S. Federal Hwy., Suite 110 • Boca Raton, FL 33432
+1 (561) 353-9707